Skip to main content
. 2017 Oct 27;93(5):252–259. doi: 10.4174/astr.2017.93.5.252

Fig. 1. Disease-free survival (A) and overall survival (B) of all patients at 1, 3, and 5 years were 69%, 52%, 38% and 90%, 78%, 74%, respectively.

Fig. 1